Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-10-22
1999-12-07
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514450, 514913, A61K 31335
Patent
active
059984678
ABSTRACT:
This invention is aimed at providing a novel medicine for oculopathy, which has as an active component thereof a 5-HT.sub.1A receptor ligand such as, for example, an alkylene dioxybenzene derivative represented by the following formula (I) ##STR1## wherein m represents an integer in the range of 2-5 and n an integer in the range of 1-3), a racemate thereof, or an acid addition salt thereof.
REFERENCES:
patent: 4684739 (1987-08-01), Kikumoto et al.
patent: 5169099 (1992-12-01), Iwata et al.
patent: 5296477 (1994-03-01), Taverne et al.
patent: 5652272 (1997-07-01), Ogawa et al.
Peroytka et al., Neuropharmacology, vol. 26, No. 2/3, pp. 139-146(1987).
Mano et al., Investigative Ophthalmology & Visual Science, vol. 37 (3) 1996 S1103 XP 000672609.
Mano Tomiya
Sogo Shunji
Fay Zohreh
Mitsubishi Chemical Corporation
LandOfFree
Medicine for oculopathy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicine for oculopathy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicine for oculopathy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-824503